Insider · CIK 0002029803
George Peoples
Files at CLDI (Calidi Biotherapeutics, Inc.). First filing -, latest -.
In brief
George Peoples files SEC Form 4 as director at CLDI (Calidi Biotherapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; George Peoples has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +4,000 | $0.00 | $0 | 4,000 | Aug 19, 2026 |
| Jul 9, 2025 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +137,078 | $0.00 | $0 | 137,078 | Jul 15, 2025 |
| Sep 20, 2024 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +20,217 | - | - | 20,217 | Oct 15, 2024 |
Questions about George Peoples
Answered from the filings on this page, as of the latest one.
Is George Peoples buying or selling?
George Peoples has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did George Peoples's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and George Peoples has 0.
Where does George Peoples file Form 4?
George Peoples has filed Form 4 at CLDI (Calidi Biotherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.